Inventor · disambiguated record
Gobinda Sarkar
Also filed as: SARKAR GOBINDA
4 granted patents·6 pending applications·9 citations·filing 2000–2019
68Inventor score
Top patents by PatentIndex Score
10 records- 0174US6562572B1Methods for amplifying nucleic acid sequencesMAYO FOUNDATION·Filed 2000·Granted May 13, 2003·6 cites·23 claims
- 0272US9597408B2Peptide-mediated non-covalent delivery of active agents across the blood-brain barrierMAYO FOUNDATION·Filed 2014·Granted Mar 21, 2017·2 cites·2 claims
- 0370US10072065B2Peptide-mediated delivery of immunoglobulins across the blood-brain barrierMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Sep 11, 2018·1 cites·17 claims
- 0457US2019322723A1Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain BarrierMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Application pending·0 cites
- 0553US10377813B2Peptide-mediated non-covalent delivery of active agents across the blood-brain barrierMAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Granted Aug 13, 2019·0 cites·17 claims
- 0651US2018340020A1Peptide-mediated delivery of immunoglobulins across the blood-brain barrierMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Application pending·0 cites
- 0744US2012107243A1Peptide-mediated non-covalent delivery of active agents across the blood-brain barrierCURRAN GEOFFRY L·Filed 2010·Application pending·0 cites
- 0842US2010119528A1Transport of Biologically Active Molecules into a Cell, Mitochondrion, or NucleusSARKAR GOBINDA·Filed 2009·Application pending·0 cites
- 0938US2014314663A1Peptide-mediated delivery of active agents across the blood-brain barrierMAYO FOUNDATION·Filed 2012·Application pending·0 cites
- 1032US2017007669A1Peptide-mediated delivery of active agents across the blood-brain barrierMAYO FOUNDATION·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gobinda Sarkar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →